Logo image of BMRC

BANK OF MARIN BANCORP/CA (BMRC) Stock Fundamental Analysis

USA - NASDAQ:BMRC - US0634251021 - Common Stock

24.12 USD
-0.16 (-0.66%)
Last: 10/1/2025, 8:25:49 PM
24.12 USD
0 (0%)
After Hours: 10/1/2025, 8:25:49 PM
Fundamental Rating

4

Taking everything into account, BMRC scores 4 out of 10 in our fundamental rating. BMRC was compared to 392 industry peers in the Banks industry. BMRC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BMRC is not valued too expensively and it also shows a decent growth rate. BMRC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BMRC had positive earnings in the past year.
BMRC had a positive operating cash flow in the past year.
BMRC had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BMRC had a positive operating cash flow.
BMRC Yearly Net Income VS EBIT VS OCF VS FCFBMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

BMRC's Return On Assets of 0.19% is on the low side compared to the rest of the industry. BMRC is outperformed by 86.22% of its industry peers.
BMRC has a worse Return On Equity (1.58%) than 86.48% of its industry peers.
Industry RankSector Rank
ROA 0.19%
ROE 1.58%
ROIC N/A
ROA(3y)0.47%
ROA(5y)0.65%
ROE(3y)4.64%
ROE(5y)5.94%
ROIC(3y)N/A
ROIC(5y)N/A
BMRC Yearly ROA, ROE, ROICBMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

BMRC has a worse Profit Margin (7.41%) than 85.71% of its industry peers.
The Operating Margin and Gross Margin are not available for BMRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 7.41%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMRC Yearly Profit, Operating, Gross MarginsBMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

4

2. Health

2.1 Basic Checks

BMRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BMRC has been reduced compared to 1 year ago.
The number of shares outstanding for BMRC has been increased compared to 5 years ago.
BMRC has a better debt/assets ratio than last year.
BMRC Yearly Shares OutstandingBMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BMRC Yearly Total Debt VS Total AssetsBMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

BMRC has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
BMRC has a Debt to FCF ratio of 0.00. This is amongst the best in the industry. BMRC outperforms 90.05% of its industry peers.
BMRC has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
BMRC has a better Debt to Equity ratio (0.00) than 88.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACCN/A
WACC17.31%
BMRC Yearly LT Debt VS Equity VS FCFBMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BMRC Yearly Current Assets VS Current LiabilitesBMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 106.56% over the past year.
BMRC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.42% yearly.
BMRC shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.84%.
The Revenue has been decreasing by -6.90% on average over the past years.
EPS 1Y (TTM)106.56%
EPS 3Y-29.7%
EPS 5Y-18.42%
EPS Q2Q%400%
Revenue 1Y (TTM)40.84%
Revenue growth 3Y-13.96%
Revenue growth 5Y-6.9%
Sales Q2Q%15.33%

3.2 Future

BMRC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.77% yearly.
BMRC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.05% yearly.
EPS Next Y64.52%
EPS Next 2Y47.62%
EPS Next 3Y24.77%
EPS Next 5YN/A
Revenue Next Year13.13%
Revenue Next 2Y12.67%
Revenue Next 3Y11.05%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BMRC Yearly Revenue VS EstimatesBMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
BMRC Yearly EPS VS EstimatesBMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.14, BMRC is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of BMRC indicates a slightly more expensive valuation: BMRC is more expensive than 78.57% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.79. BMRC is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 12.30, which indicates a correct valuation of BMRC.
Based on the Price/Forward Earnings ratio, BMRC is valued a bit more expensive than the industry average as 67.60% of the companies are valued more cheaply.
BMRC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.21.
Industry RankSector Rank
PE 19.14
Fwd PE 12.3
BMRC Price Earnings VS Forward Price EarningsBMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as BMRC.
Industry RankSector Rank
P/FCF 12.15
EV/EBITDA N/A
BMRC Per share dataBMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

BMRC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BMRC's earnings are expected to grow with 24.77% in the coming years.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y47.62%
EPS Next 3Y24.77%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.08%, BMRC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.52, BMRC pays a bit more dividend than its industry peers.
BMRC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.08%

5.2 History

The dividend of BMRC has a limited annual growth rate of 4.66%.
BMRC has been paying a dividend for at least 10 years, so it has a reliable track record.
BMRC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.66%
Div Incr Years0
Div Non Decr Years19
BMRC Yearly Dividends per shareBMRC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

233.87% of the earnings are spent on dividend by BMRC. This is not a sustainable payout ratio.
BMRC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP233.87%
EPS Next 2Y47.62%
EPS Next 3Y24.77%
BMRC Yearly Income VS Free CF VS DividendBMRC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M
BMRC Dividend Payout.BMRC Dividend Payout, showing the Payout Ratio.BMRC Dividend Payout.PayoutRetained Earnings

BANK OF MARIN BANCORP/CA

NASDAQ:BMRC (10/1/2025, 8:25:49 PM)

After market: 24.12 0 (0%)

24.12

-0.16 (-0.66%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-28 2025-07-28/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners63.4%
Inst Owner Change2.66%
Ins Owners8.96%
Ins Owner Change-1.37%
Market Cap389.06M
Analysts81.67
Price Target27.54 (14.18%)
Short Float %3.62%
Short Ratio5.9
Dividend
Industry RankSector Rank
Dividend Yield 4.08%
Yearly Dividend1
Dividend Growth(5Y)4.66%
DP233.87%
Div Incr Years0
Div Non Decr Years19
Ex-Date08-07 2025-08-07 (0.25)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-10.52%
Min EPS beat(2)-14.4%
Max EPS beat(2)-6.63%
EPS beat(4)2
Avg EPS beat(4)-0.61%
Min EPS beat(4)-14.4%
Max EPS beat(4)14.98%
EPS beat(8)3
Avg EPS beat(8)-23.4%
EPS beat(12)4
Avg EPS beat(12)-19.54%
EPS beat(16)7
Avg EPS beat(16)-5.3%
Revenue beat(2)0
Avg Revenue beat(2)-3.98%
Min Revenue beat(2)-5.18%
Max Revenue beat(2)-2.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.72%
Min Revenue beat(4)-6.4%
Max Revenue beat(4)-2.77%
Revenue beat(8)0
Avg Revenue beat(8)-5.32%
Revenue beat(12)2
Avg Revenue beat(12)-3.53%
Revenue beat(16)6
Avg Revenue beat(16)-0.42%
PT rev (1m)0%
PT rev (3m)10.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.64%
EPS NY rev (1m)0%
EPS NY rev (3m)1.03%
Revenue NQ rev (1m)-2.08%
Revenue NQ rev (3m)-3.37%
Revenue NY rev (1m)1.28%
Revenue NY rev (3m)-4.87%
Valuation
Industry RankSector Rank
PE 19.14
Fwd PE 12.3
P/S 4.17
P/FCF 12.15
P/OCF 11.59
P/B 0.89
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)1.26
EY5.22%
EPS(NY)1.96
Fwd EY8.13%
FCF(TTM)1.98
FCFY8.23%
OCF(TTM)2.08
OCFY8.63%
SpS5.78
BVpS27.19
TBVpS22.53
PEG (NY)0.3
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.19%
ROE 1.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 7.41%
GM N/A
FCFM 34.33%
ROA(3y)0.47%
ROA(5y)0.65%
ROE(3y)4.64%
ROE(5y)5.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 68.45%
Cap/Sales 1.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 463.25%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC17.31%
ROIC/WACCN/A
Cap/Depr(3y)46.73%
Cap/Depr(5y)41.79%
Cap/Sales(3y)1.32%
Cap/Sales(5y)1.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.56%
EPS 3Y-29.7%
EPS 5Y-18.42%
EPS Q2Q%400%
EPS Next Y64.52%
EPS Next 2Y47.62%
EPS Next 3Y24.77%
EPS Next 5YN/A
Revenue 1Y (TTM)40.84%
Revenue growth 3Y-13.96%
Revenue growth 5Y-6.9%
Sales Q2Q%15.33%
Revenue Next Year13.13%
Revenue Next 2Y12.67%
Revenue Next 3Y11.05%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40.08%
FCF growth 3Y-14.28%
FCF growth 5Y-7.17%
OCF growth 1Y-41.29%
OCF growth 3Y-14.42%
OCF growth 5Y-7.07%